COURTNEY GRANADERO: Open Payments
NPI 1154996221 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$857 in 32 payments from 14 companies in 2025. Trend: 2023 $1,251 · 2024 $1,378 · 2025 $857
Food & beverage: $857
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $189 |
| GENZYME CORPORATION | 2 | $164 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $110 |
| GlaxoSmithKline, LLC. | 4 | $75 |
| Verona Pharma, Inc. | 3 | $63 |
| Regeneron Healthcare Solutions, Inc. | 3 | $58 |
| Becton, Dickinson and Company | 2 | $51 |
| Mallinckrodt Hospital Products Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| United Therapeutics Corporation | 1 | $23 |
Products named: DUPIXENT, FASENRA, OFEV, NUCALA, Ohtuvayre, ACTHAR, LUTONIX Drug Coated Balloon, AIRSUPRA.
Industry payments across NC — which companies pay providers there.
